Cargando…
Amnestic MCI patients’ experiences after disclosure of their amyloid PET result in a research context
BACKGROUND: Biomarkers such as amyloid imaging are increasingly used for diagnosis in the early stages of Alzheimer’s disease. Very few studies have examined this from the perspective of the patient. To date, there is only limited evidence about how patients experience and value disclosure in an ear...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712105/ https://www.ncbi.nlm.nih.gov/pubmed/29197423 http://dx.doi.org/10.1186/s13195-017-0321-3 |